Hematopoietic-cell-specific homozygous deletion of Asxl1 resulted in MDS characterized by progressive, multilineage cytopenias and dysplasia accompanied by increased numbers of less differentiated hematopoietic stem and progenitor cells. The gene discussed is ASXL1; the disease is myelodysplastic syndrome.